Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Active not recruiting 3Unknown 2Terminated 2Recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Conditions

Neoplasms 85Carcinoma, Non-Small-Cell Lung 75Breast Neoplasms 73Recurrence 64Colorectal Neoplasms 62Pancreatic Neoplasms 59Multiple Myeloma 57Melanoma 56Carcinoma, Hepatocellular 56Advanced Solid Tumor 55Leukemia, Myeloid, Acute 53Advanced Solid Tumors 53Lymphoma 52Neoplasm Metastasis 50Stomach Neoplasms 45Precursor Cell Lymphoblastic Leukemia-Lymphoma 44Solid Tumor 39Lymphoma, B-Cell 39Ovarian Neoplasms 38Lymphoma, Non-Hodgkin 37Lung Neoplasms 35Glioblastoma 35Prostatic Neoplasms 34Leukemia 28Head and Neck Neoplasms 27Leukemia, Lymphocytic, Chronic, B-Cell 26Uterine Cervical Neoplasms 25Burkitt Lymphoma 24Esophageal Neoplasms 22Urinary Bladder Neoplasms 18

Interventions

SH-1028 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Unknown × Advanced Solid Cancer × Clear all
NCT05770310 2023-03-15

A Phase I Study Of JS015 in Patients With Advanced Solid Tumors

Shanghai Junshi Bioscience Co., Ltd.

Phase 1 Unknown
114 enrolled

Advanced Solid Cancer

NCT03618043 2019-01-29

Safety and Tolerability of SH-1028 in Patients With Advanced Solid Cancer

Nanjing Sanhome Pharmaceutical, Co., Ltd.

Phase 1 Unknown
14 enrolled

Advanced Solid Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡